Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in the rabbit

Japanese Journal of Pharmacology
K TawaraM Tomikawa

Abstract

Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in aorta and coronary artery was studied in cholesterol-fed rabbits. Probucol treatment (0.5% in diet) resulted in reducing HDL cholesterol and serum apo A-I levels significantly, while pantethine treatment (0.25%-0.75% in diet) tended to increase HDL cholesterol and serum apo A-I levels. Combined treatment with these two drugs showed a significant prevention in the reduction of HDL cholesterol and serum apo A-I levels by probucol alone. Probucol or pantethine treatment reduced effectively (V) LDL cholesterol and serum apo B levels, and these effects were accelerated additively when the two drugs were given concurrently. Atheromatous lesions in aorta and coronary artery in cholesterol-fed rabbits were prevented by the treatment with probucol (0.5% in diet) or pantethine (0.75% in diet) for 24 weeks. The combined treatment with these two drugs showed more marked prevention than either drug alone. From these findings, it is concluded that the combined treatment of probucol with pantethine is effective for improvement of serum lipoprotein disorders and for prevention of the incidence of atheromatous le...Continue Reading

Citations

Jan 1, 1994·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·T M BocanB R Krause
Feb 1, 1991·Clinical Cardiology·G M Chisolm
Jan 1, 1993·Free Radical Biology & Medicine·M Kuzuya, F Kuzuya
Sep 24, 2004·Physiological Reviews·Roland Stocker, John F Keaney
May 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S ParthasarathyD Steinberg
Jan 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·Y B de RijkeT J van Berkel
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·D S BaumannA Daugherty
Mar 1, 1993·Medicinal Research Reviews·R L JacksonC E Thomas
Mar 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·Y AradH N Ginsberg
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·K PrasadP Lee
Jan 1, 1992·Progress in Lipid Research·S Parthasarathy, S M Rankin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.